Your nurse and our Medical Director screen for risk factors before every drip
Compounded vials may use different diluents or pH adjusters, which can influence comfort at injection and stability in storage
Administration of CCK, in humans and animals, inhibits food intake by reducing meal size and its duration.17,18 Recent work suggests that CCK-A receptors expressed by vagal afferent neurons are an important target for CCK in producing sensations of satiety, as well as inhibiting gastric emptying and stimulating pancreatic digestive enzyme secretion.19 In animals it is thought that the reduction in food intake may be mediated by a paracrine/neurocrine effect since high concentrations of CCK occur only locally to the site of release.20 Thus, locally released CCK may increase vagal tone, without a significant increase in plasma CCK level
Pharmacokinetic analysis revealed that there was no discernible accumulation of SalB in the body as the maximum plasma concentration and area under the curve (AUC) rose proportionately with increasing doses (Newman, 2017)
The side effect profile compares favorably to Wegovy (semaglutide), which has a 44% nausea rate compared to Retatrutides 28%